The history of microscopes is one of ever higher magnification, enabling scientists to peer deeper and deeper into the minute details of nature invisible to the naked eye.
The latest category of this powerful tool is what’s called a cryo-electron microscope, and its groundbreaking properties are revolutionizing the way scientists are imaging the smallest of structures — especially in the life sciences.
The cryo-electron microscope, or cryo-EM, is allowing scientists to image structures as small as viruses and ribosomes — the part of the cell where proteins are synthesized. More importantly, it does this without the need to turn the samples into crystals — the often tricky step needed when using X-ray crystallography, which has until recently been the go-to technology when imaging microscopic structures.
“We call it a resolution revolution,” says Seungil Han, Associate Research Fellow at Pfizer’s Groton, Connecticut, site, which is currently home to the only fully operational Titan Krios microscope in the world outside of academia. It began operating in October 2016.
“The requirement of X-ray crystallography is that you need to obtain a diffracting crystal to get atomic resolution. That has been a big hurdle if you’re working on challenging targets,” Han says, referring to certain irregular proteins that can be incredibly difficult to crystallize. “Almost every target we’re working on now is very challenging.”
With cryo-EM, you don’t need the sample to be in crystal form, and you can still achieve a resolution of about 3 angstroms — three-tenths of a nanometer. A chlorine atom, for example, has a radius of about 1 angstrom.
Why Electron Beams Are Used Instead of Light to See the Truly Tiny
The theoretical limit of resolution of an optical microscope is on the order of the wavelength of the light that is used. Since visible light has a wavelength of about 4,000 to 7,000 angstroms, an optical microscope — even under ideal conditions — can’t reveal structures much smaller than that .
However, when you use a beam of electrons as the source of “light” — as is done with transmission electron microscopes — you can achieve resolutions on the order of 1 angstrom.
Putting the Cryo in Electron Microscopes
Shooting a beam of high-energy electrons onto a sample is fine if it’s an inert object, but when the target is biological, like a fragile protein, that’s a recipe for damage.
“If you shoot a high dose of electrons, you will pretty much fry a biological sample,” Han explains, noting that’s one reason why the target is frozen to liquid nitrogen temperatures. That’s where the cryo-EM gets the “cryo” part of its name.
The cryo-EM at Pfizer’s Groton site is a hulking structure about the size of a large van that sits in a darkened, temperature-controlled room. Once a sample is loaded into the microscope, the machine can operate autonomously for a few days, spitting out image files that are 2 to 3 terabytes in size — the equivalent of thousands of high-definition movies.
To process that huge amount of image data, Han and his team employ a computer with powerful graphical processing units developed in the video gaming business.
“If your processing capabilities are too slow, you can’t keep up with the data,” Han says, noting that advances in computer hardware and programming were integral in making cryo-EM viable as much as the detector itself.
And because the cryo-EM can create 3-D images, or even “movies,” a cryo-EM image of the same resolution as an X-ray crystallography image is more useful, says Han, a biochemist who was trained as an X-ray crystallographer.
“We’ve already gotten some atomic structures since the grand opening, and we’re quite excited about it,” Han says.
If there is a bottleneck to the growth of cryo-EM, it hasn’t been the technology, but rather the difficulty in recruiting researchers trained in the field, Han says. “It’s a hot new field.”
How Cryo-EM Imaging Can Help Scientists
It’s one thing to know the structure of a protein. But how does that help scientists, for example, create better medicines?
In the case of the ribosome — the cell’s protein factory — a high-resolution image can take the guessing game out of drug design, Han says. “We can find the compound binding site, see how it interacts and improve the potency.”
Cryo-EM could also help scientists create better vaccines, such as the RSV vaccine, which is given to women to protect their babies from the respiratory syncytial virus (RSV), Han says as he points to a poster of the triangular shaped virus successfully imaged in his lab recently.
“We’re really keen on making an impact using this technology,” Han says.
When you think of a statistician, you may picture a math whiz hastily scrawling formulas on a white board in the halls of academia or the trading floors of finance. But statisticians—specifically, biostatisticians—play a critical role in discovering and developing new medicines.
In the year since the pandemic struck, the world has watched one of the greatest real-life dramas of all time unfold: the quest for a vaccine. In the past, drug development and clinical trials were of interest to a relatively small group of scientists, regulators and health care professionals. But with the threat of COVID-19 looming large, time has not been a luxury. The race for a vaccine has become a true spectacle, carrying with it the potential to save untold numbers of lives, globally.
By the end of February 2021, just over one year since the novel coronavirus emerged and disrupted our lives, approximately 136 million people worldwide had received at least one dose of COVID-19 vaccine.1 Interestingly, the disruption itself fueled the innovation that allowed such rapid development and deployment of the vaccine. Government issued stay-at-home orders, combined with a desire to protect researchers and the public from infectious disease, made it highly challenging to conduct clinical trials as usual.